Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oestrogen replacement therapy: physiological considerations and new applications.

H L Judd

    Bailliere'S Clinical Endocrinology and Metabolism
    |February 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Estrogen replacement therapy and gallbladder disease in postmenopausal women.

    Menopause (New York, N.Y.)·2000
    Same author

    Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study.

    Circulation·1999
    Same author

    Estrogen replacement therapy and breast cancer.

    Fertility and sterility·1999
    Same author

    Agreement in assessing endometrial pathology: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial.

    Journal of women's health·1998
    Same author

    Comparison of the impact of transdermal versus oral estrogens on biliary markers of gallstone formation in postmenopausal women.

    The Journal of clinical endocrinology and metabolism·1998
    Same author

    Nafarelin vs. leuprolide acetate depot for endometriosis. Changes in bone mineral density and vasomotor symptoms. Nafarelin Study Group.

    The Journal of reproductive medicine·1997

    Estrogen replacement therapy (ERT) requires individualized treatment plans due to incomplete understanding of menopause impacts and ERT benefit/risk. Combining estrogen with progestin and exploring new delivery methods can improve outcomes for women needing ERT.

    Area of Science:

    • Reproductive Endocrinology
    • Women's Health
    • Pharmacology

    Background:

    • The comprehensive health effects of menopause are not fully understood.
    • The precise benefit-to-risk ratio of estrogen replacement therapy (ERT) remains undefined.

    Purpose of the Study:

    • To highlight the need for individualized treatment in hormone therapy.
    • To discuss strategies for optimizing estrogen replacement therapy (ERT) outcomes.

    Main Methods:

    • Literature review on menopause and hormone replacement therapy.
    • Analysis of current treatment guidelines and emerging therapeutic approaches.

    Main Results:

    • Broad guidelines for ERT are not yet feasible.
    • Individualized treatment plans are essential for effective hormone therapy.

    Related Experiment Videos

    Conclusions:

    • Estrogen replacement therapy (ERT) necessitates personalized patient approaches.
    • Combining estrogen with progestin and utilizing novel administration routes can mitigate risks and enhance benefits.
    • Further research is required to fully elucidate the long-term impacts of menopause and ERT.